OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States — September 2022–August 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Showing 4 citing articles:
Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024
Jennifer DeCuir, Amanda B. Payne, Wesley H. Self, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 8, pp. 180-188
Open Access | Times Cited: 44
Jennifer DeCuir, Amanda B. Payne, Wesley H. Self, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 8, pp. 180-188
Open Access | Times Cited: 44
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024
C. Kevin, Diya Surie, Adam S. Lauring, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 9
C. Kevin, Diya Surie, Adam S. Lauring, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 9
Use of Additional Doses of 2024–2025 COVID-19 Vaccine for Adults Aged ≥65 Years and Persons Aged ≥6 Months with Moderate or Severe Immunocompromise: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024
Lauren E. Roper, Monica Godfrey, Ruth Link‐Gelles, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 49, pp. 1118-1123
Open Access | Times Cited: 1
Lauren E. Roper, Monica Godfrey, Ruth Link‐Gelles, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 49, pp. 1118-1123
Open Access | Times Cited: 1
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity — IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024
C. Kevin, Diya Surie, Adam S. Lauring, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
C. Kevin, Diya Surie, Adam S. Lauring, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
